Cargando…

Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts

INTRODUCTION: As novel therapies for chronic kidney disease (CKD) in type 2 diabetes mellitus (T2DM) become available, their long-term benefits should be evaluated using CKD progression models. Existing models offer different modeling approaches that could be reused, but it may be challenging for mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pöhlmann, Johannes, Bergenheim, Klas, Garcia Sanchez, Juan-Jose, Rao, Naveen, Briggs, Andrew, Pollock, Richard F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991383/ https://www.ncbi.nlm.nih.gov/pubmed/35290625 http://dx.doi.org/10.1007/s13300-022-01208-0

Ejemplares similares

Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model
por: McEwan, Philip, et al.
Publicado: (2015)

The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus
por: McEwan, Phil, et al.
Publicado: (2016)

The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications
por: Rydén, Anna, et al.
Publicado: (2016)

Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease—prospective data from the German Chronic Kidney Disease cohort
por: Ruhe, Johannes, et al.
Publicado: (2023)

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
por: Bennett, Hayley, et al.
Publicado: (2014)

Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials
por: Garcia Sanchez, Juan Jose, et al.
Publicado: (2021)

A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose
por: Kennedy, Nicholas A., et al.
Publicado: (2023)

Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design
por: Sugrue, Daniel M., et al.
Publicado: (2019)

Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China
por: Hu, Shanlian, et al.
Publicado: (2023)

Chronic kidney disease in patients with diabetes mellitus
por: Nordheim, Espen, et al.
Publicado: (2021)

ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study
por: Hui, Miao, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease
por: Cao, Qinghua, et al.
Publicado: (2022)

Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review
por: Cooper, Jacie T., et al.
Publicado: (2020)

The expression of two isoforms of matrix metalloproteinase-2 in aged mouse models of diabetes mellitus and chronic kidney disease
por: Rhee, Harin, et al.
Publicado: (2018)

Stress levels predict substantial improvement in pain intensity after 10 to 12 years in women with fibromyalgia and chronic widespread pain: a cohort study
por: Bergenheim, Anna, et al.
Publicado: (2019)

Increased levels of oral Streptococcus-derived d-alanine in patients with chronic kidney disease and diabetes mellitus
por: Nakade, Yusuke, et al.
Publicado: (2022)

Characteristics and comparison between diabetes mellitus and non-diabetes mellitus among chronic kidney disease patients: A cross-sectional study of the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)
por: Zhang, Jun-Jun, et al.
Publicado: (2017)

Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study
por: Roth, Jan A, et al.
Publicado: (2020)

Epidemiology and burden of chronic kidney disease-associated pruritus
por: Kim, Dana, et al.
Publicado: (2021)

The role of diabetes mellitus and hypertension in chronic kidney disease
por: Ghaderian, Seyed Bahman, et al.
Publicado: (2014)

Management of diabetes mellitus in patients with chronic kidney disease
por: Hahr, Allison J., et al.
Publicado: (2015)

Prevalence of Diabetes Mellitus in Patients with Chronic Kidney Disease
por: Stojceva-Taneva, Olivera, et al.
Publicado: (2016)

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
por: Willis, Michael, et al.
Publicado: (2020)

Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort
por: Busch, Martin, et al.
Publicado: (2016)

Mixture Cure Models in Oncology: A Tutorial and Practical Guidance
por: Felizzi, Federico, et al.
Publicado: (2021)

Fusion of Graph and Tabular Deep Learning Models for Predicting Chronic Kidney Disease
por: Rao, Patike Kiran, et al.
Publicado: (2023)

Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study
por: Gosmanova, Elvira O., et al.
Publicado: (2021)

Risk of Chronic Kidney Disease in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Gosmanova, Elvira, et al.
Publicado: (2021)

Evidence of chronic kidney disease in veterans with incident diabetes mellitus
por: Gatwood, Justin, et al.
Publicado: (2018)

Nomogram-Based Chronic Kidney Disease Prediction Model for Type 1 Diabetes Mellitus Patients Using Routine Pathological Data
por: Chowdhury, Nakib Hayat, et al.
Publicado: (2022)

The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial
por: McEwan, Phil, et al.
Publicado: (2021)

Low‐dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity‐related chronic kidney disease
por: Larkin, Benjamin P., et al.
Publicado: (2022)

An early prediction model for chronic kidney disease
por: Zhao, Jing, et al.
Publicado: (2022)

Suppression of muscle wasting by the plant‐derived compound ursolic acid in a model of chronic kidney disease
por: Yu, Rizhen, et al.
Publicado: (2016)

Gut–Kidney Axis Investigations in Animal Models of Chronic Kidney Disease
por: Bartochowski, Piotr, et al.
Publicado: (2022)

Refinement of the spinal cord injury rat model and validation of its applicability as a model for memory loss and chronic pain
por: Harikrishnan, V.S., et al.
Publicado: (2021)

Machine Learning Models for the Prediction of Renal Failure in Chronic Kidney Disease: A Retrospective Cohort Study
por: Su, Chuan-Tsung, et al.
Publicado: (2022)

Mouse Models of Diabetes, Obesity and Related Kidney Disease
por: Glastras, Sarah J., et al.
Publicado: (2016)

Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort
por: Pollock, Carol, et al.
Publicado: (2022)

Association between diabetes mellitus and health-related quality of life among patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)
por: Chen, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iqeefmmanufkt05g1d56ec4oh4